Pharma BD Deal Intelligence

Hospira, Inc. / Orchid Chemicals & Pharmaceuticals Ltd. (Generic Injectables business)

2009 · Acquisition/Merger · $400M · Complete

Hospira acquired Orchid Chemicals & Pharmaceuticals' generic injectables (beta-lactam) business and Indian manufacturing/R&D facility for ~$400M cash (closed Mar 30, 2010). Remove the 'Source:' clause.

Key facts

• Announced Dec 15, 2009
• Deal value $400M
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals